Alternatives to CSF Biosciences
CSF Biosciences is a Biotech tool: develops novel protein engineering and directed evolution technologies for therapeutic discovery. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to CSF Biosciences
- Website
Absci56BiotechVancouver, United States$100.5MAI-powered drug discovery and development platform for biologics.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Hexagon Bio57BiotechMenlo Park, United States$100.0MDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Cellcolabs55BiotechTel Aviv, Israel$15.5MAI-powered platform for personalized cell therapy development and manufacturing.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
Showing the 20 closest matches. See the rest on the CSF Biosciences profile.